Notably, the immune correlation of the two DE-RBPs is shown in Table 3, and PIWIL4 was demonstrated to be differentially expressed in groups with or without immunotherapy for melanoma (p = 0.0385)[41]. The gene discussed is PIWIL4; the disease is melanoma.